Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02763345
Other study ID # 51750
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2016
Est. completion date February 28, 2017

Study information

Verified date January 2024
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Community Case Management (CCM) is a clinical decision aid used by frontline Health Surveillance Assistants (HSAs) in Malawi to manage uncomplicated cases of pneumonia and malaria (amongst other conditions). Children identified has having complicated illness are urgently referred to larger health facilities better equipped to clinically manage these more complex presentations. There is evidence to suggest HSAs are missing opportunities to refer seriously ill children, and parents/caregivers are failing to comply with urgent referral recommendations when given; reducing the overall effectiveness of the CCM strategy. Use of mobile technology for deploying CCM has been demonstrated in prior research as feasible to evaluate, acceptable to health workers and parents/caregivers and improving health worker fidelity to the guidelines, but it is unknown if this translates into increased referral and referral completion rates. This trial seeks to evaluate the added value of a purpose developed mobile solution for CCM, called Supporting LIFE electronic Community Case Management (SL eCCM App) on HSA referral and parent/caregiver health seeking behavior.


Recruitment information / eligibility

Status Completed
Enrollment 6995
Est. completion date February 28, 2017
Est. primary completion date February 28, 2017
Accepts healthy volunteers No
Gender All
Age group 2 Months to 59 Months
Eligibility Inclusion Criteria: - Parents/caregivers aged =18 years with spoken fluency in Chichewa, Tonga and Tumbuka - Children aged =2 months to <5 years - Able/willing to give voluntary verbal consent Exclusion Criteria: - Parents/caregivers aged <18 years - Children aged <2 months or =5 years - Children who are convulsing or unconscious/unresponsive at presentation - Parents/caregivers unable/unwilling to give voluntary verbal consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Supporting LIFE electronic Community Case Management
The SL eCCM App is smartphone application developed to run on Android operating systems 3.0 Honeycomb and above. The SL eCCM App represents an electronic format of the WHO and UNICEFs paper-based CCM clinical decision rule, currently adopted as national policy in Malawi for assessing children presenting to village clinics with acute illness.The App includes a tap-sensitive breath counter for measuring breathing rate.
Standard care


Locations

Country Name City State
n/a

Sponsors (6)

Lead Sponsor Collaborator
University of Washington Imperial College London, Luke International Norway, Lund University, Mzuzu University, University College Cork

Outcome

Type Measure Description Time frame Safety issue
Primary Health worker initiated referral of children to higher-level health facilities at the index visit (study enrollment)
Primary Attendance/non-attendance of parent/caregivers given urgent referral recommendation at higher-level health facilities 7-days post-enrollment
Secondary Barriers and facilitators to parent/caregiver compliance with referral recommendations <2-weeks post-enrollment
Secondary Acceptability of the SL eCCM App to HSAs and parents/caregivers <2-weeks post-enrollment
Secondary Household-level costs associated with healthcare seeking behavior < 2-weeks post-enrollment
See also
  Status Clinical Trial Phase
Completed NCT00550706 - Drug Utilization Prevalence in a Pediatric Care Medical Center N/A
Completed NCT01033799 - Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers N/A
Completed NCT00761462 - BAY 0 9867 Cipro Pediatric Use Study (QUIP) Phase 3
Completed NCT05088421 - A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers Phase 1
Completed NCT00828971 - A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs Phase 3
Completed NCT05468723 - Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
Recruiting NCT02162966 - Safety and Efficacy Study of High Dose Colistin Phase 4
Recruiting NCT00001281 - Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Active, not recruiting NCT02654210 - LoewenKIDS - Infections and the Development of the Immune System
Completed NCT02226263 - Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics Phase 2
Terminated NCT00211471 - Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). Phase 2
Active, not recruiting NCT04342702 - A Study on the Prospective Cohort Library of COVID-19 in Southeran
Completed NCT02134548 - Sensitivity Study of Diagnostic for Detection of Chagas Infection N/A
Active, not recruiting NCT01611025 - Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time N/A
Completed NCT01361997 - Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination Phase 3
Completed NCT00638677 - Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier Phase 4
Completed NCT02434848 - A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses Phase 2/Phase 3
Completed NCT02544139 - Specificity Study of Diagnostic for Chagas Disease N/A
Completed NCT00276198 - Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants Phase 3
Completed NCT02111564 - A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients Phase 3